Drug Farm collects $56M
February 10, 2021- Share:
Biotech startup Drug Farm has raised $56 million ahead of clinical trials for its treatment of hepatitis B and other liver diseases. The company, which has dual headquarters in the US and China, is backed by investors including BioVeda China Fund, WuXi AppTec, South China Venture Capital, Detong Capital and Zhejiang United Investment Group.
- Share:
-
-
-
-